Lamdong Pharmaceutical JSC (HNX:LDP)
Vietnam
· Delayed Price · Currency is VND 7,700.00
-300.00 (-3.75%)
At close: Apr 28, 2026
HNX:LDP Revenue
Lamdong Pharmaceutical JSC had revenue of 59.87B VND in the quarter ending March 31, 2026, a decrease of -1.69%. This brings the company's revenue in the last twelve months to 242.87B, up 4.00% year-over-year. In the year 2025, Lamdong Pharmaceutical JSC had annual revenue of 243.91B with 11.91% growth.
Revenue (ttm)
242.87B
Revenue Growth
+4.00%
P/S Ratio
0.59
Revenue / Employee
930.55M
Employees
261
Market Cap
144.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 243.91B | 25.95B | 11.91% |
| Dec 31, 2024 | 217.96B | 31.96B | 17.18% |
| Dec 31, 2023 | 186.00B | -1.41B | -0.75% |
| Dec 31, 2022 | 187.41B | 25.51B | 15.76% |
| Dec 31, 2021 | 161.90B | -217.76B | -57.36% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Phong Phu Pharmaceutical JSC | 139.74B |
| SPM Corporation | 217.45B |
| Vimedimex Medi-Pharma JSC | 812.98B |
| American Vietnamese Biotech Incorporation | 154.07B |
| Ben Tre Pharmaceutical JSC | 860.31B |
| Cai Lay Veterinary Pharmaceutical JSC | 152.40B |
| Mediplantex National Pharmaceutical JSC | 366.83B |
| Vidipha Central Pharmaceutical JSC | 971.25B |